Stagezero Life Stock Price, News & Analysis
Company Description
Stagezero Life (OTC Link: SZLSF) is a publicly traded diagnostics & research company in the Healthcare sector. The company has a market capitalization of $3.6M.
SZLSF stock has declined 89.8% over the past year. Shares last traded at $0.0051.
This page provides a comprehensive overview of SZLSF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Stagezero Life (SZLSF) stock last traded at $0.0051. Over the past 12 months, the stock has lost 89.8%. At a market capitalization of $3.6M, SZLSF is classified as a micro-cap stock with approximately 123.6M shares outstanding.
Latest News
Stagezero Life has 10 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 1 with negative movement. Key topics include earnings, partnership. View all SZLSF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
SZLSF Company Profile & Sector Positioning
Stagezero Life (SZLSF) operates in the Diagnostics & Research industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing SZLSF often look at related companies in the same sector, including Interpace Biosciences Inc (IDXG), Imd Companies (ICBU), Leveljump Health (JMPHF), Rennova Health (RNVA), and Hypha Labs (FUNI). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate SZLSF's relative position within its industry.